tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Similar Stocks

Compare
597 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cue Biopharma
$1.32
$86.79M
-34.33%
0 Buy
0 Hold
0 Sell
Moderate Buy
Agenus
$3.32
$80.93M
-75.41%
1 Buy
1 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$1.42
$175.97M
-79.21%
3 Buy
2 Hold
0 Sell
Moderate Buy
Affimed
$1.04
$15.53M
-80.49%
3 Buy
0 Hold
0 Sell
Strong Buy
Adaptimmune Therapeutics
$0.56
$148.28M
-62.23%
2 Buy
0 Hold
0 Sell
Moderate Buy
Corvus Pharmaceuticals
$4.19
$283.37M
82.17%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
CUE
Cue Biopharma
1.32
-0.72
-35.29%
AGEN
Agenus
3.32
-10.18
-75.41%
FATE
Fate Therapeutics
1.42
-5.46
-79.36%
AFMD
Affimed
1.04
-4.29
-80.49%
ADAP
Adaptimmune Therapeutics
0.56
-0.82
-59.42%
CRVS
Corvus Pharmaceuticals
4.19
1.88
81.39%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis